This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zanesi, N. Articles by Huebner, K. Search for Related Content PubMed PubMed Citation Articles by Zanesi, N. Articles by Huebner, K.

Lung Cancer Susceptibility in Fhit-Deficient Mice Is Increased by Vhl Haploinsufficiency

¹ Comprehensive Cancer Center, Ohio State University, Columbus, Ohio; ² Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania; ³ Istituto Superiore Sanita, Rome, Italy; and ⁴ Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana

Corresponding author: Kay Huebner, Ohio State University Comprehensive Cancer Center, Room 455c, Wiseman Hall, 410 West 12th Avenue, Columbus, OH 43210. Phone: 614-292-4850; Fax: 614-292-3312; E-mail: kay.huebner{at}osumc.edu.

The FHIT gene plays important roles in cancer development, including lung cancers, in which the Fhit protein is frequently lost. To determine if Fhit-deficient mice exhibit increased susceptibility to carcinogen-induced lung cancer, mice were treated with the pulmonary carcinogen 4-methylnitrosamino-1-3-pyridyl-1-butanone. Wild-type and Fhit-deficient animals did not exhibit significantly different frequencies of lung lesions, but Fhit^–/– mice showed significantly increased average tumor volume (1.62 mm³) and multiplicity in tumor-bearing mice, compared with wild-type mice (0.70 mm³). Tumors of Fhit^–/– mice were all carcinomas, whereas Fhit^+/+ mice did not develop carcinomas. To determine if Fhit absence, in combination with deficiency of an additional 3p tumor suppressor, would affect the frequency of tumor induction, we examined the spontaneous and dimethylnitrosamine-induced tumor phenotype of Fhit^–/–Vhl^+/– mice. Whereas no spontaneous lung tumors were observed in Fhit^–/– or Vhl^+/– mice, 44% of Fhit^–/–Vhl^+/– mice developed adenocarcinomas by 2 years of age. Dimethylnitrosamine (6 mg/kg body weight) induced lung tumors (adenomas and carcinomas) in 100% of Fhit^–/–Vhl^+/– mice and adenomas in 40% of Fhit^–/– mice by 20 months of age. Thus, double deficiency in murine homologues of 3p suppressor genes, including haploinsufficiency of Vhl, predisposes to spontaneous and induced lung cancers, showing that Fhit-deficient mice will be useful, in combination with other 3p tumor suppressors, in recapitulating a pattern of lung cancer development similar to the human pattern; such double- or triple-deficient mice will be excellent lung cancer prevention and therapy models.

This article has been cited by other articles:

				S. De Flora, F. D'Agostini, A. Izzotti, N. Zanesi, C. M. Croce, and R. Balansky Molecular and Cytogenetical Alterations Induced by Environmental Cigarette Smoke in Mice Heterozygous for Fhit Cancer Res., February 1, 2007; 67(3): 1001 - 1006. [Abstract] [Full Text] [PDF]

				S. Semba and K. Huebner Protein Expression Profiling Identifies Cyclophilin A as a Molecular Target in Fhit-Mediated Tumor Suppression Mol. Cancer Res., August 1, 2006; 4(8): 529 - 538. [Abstract] [Full Text] [PDF]

				A. Dutt and K.-K. Wong Mouse models of lung cancer. Clin. Cancer Res., July 15, 2006; 12(14): 4396s - 4402s. [Abstract] [Full Text] [PDF]

				R. Balansky, F. D'Agostini, G. Ganchev, A. Izzotti, B. Di Marco, R. A. Lubet, N. Zanesi, C. M. Croce, and S. De Flora Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: Chemoprevention by budesonide and N-acetylcysteine PNAS, May 16, 2006; 103(20): 7823 - 7828. [Abstract] [Full Text] [PDF]

				F. D'Agostini, A. Izzotti, R. Balansky, N. Zanesi, C. M. Croce, and S. De Flora Early loss of fhit in the respiratory tract of rodents exposed to environmental cigarette smoke. Cancer Res., April 1, 2006; 66(7): 3936 - 3941. [Abstract] [Full Text] [PDF]